93. 原発性胆汁性胆管炎 ［臨床試験数：230，薬物数：215（DrugBank：51），標的遺伝子数：34，標的パスウェイ数：107］
Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|November 5, 2020||31/10/2020||Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1||A Randomized Controlled Open-label Clinical Trial of Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1||Hepatitis;Primary Biliary Cholangitis;Autoimmune||Drug: Ursodeoxycholic acid combined with total glucosides of paeony;Drug: Ursodeoxycholic acid only||West China Hospital||NULL||Not yet recruiting||18 Years||75 Years||All||137||Phase 4||NULL|
|December 2016||15/10/2016||Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome||Biochemical Response of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Induced by Ursodeoxycholic Acid Only or Combination Therapy of Immunosuppressive Agents||Hepatitis, Autoimmune;Cholangitis;Liver Cirrhosis, Biliary;Cholestasis||Drug: Ursodeoxycholic acid combination of immunosuppressive agents;Drug: Ursodeoxycholic Acid||Xiaoli Fan||NULL||Recruiting||18 Years||75 Years||All||53||N/A||China|